https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/MorphoSys-Health-Canada-Grants-Marketing-Authorization-for-Minjuvi-tafasitamab-in-Combination-36246383/?utm_source=telegram&utm_medium=social&utm_campaign=share